Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users

Laetitia Penso, Mounya Abboud, Mahmoud Zureik, Emilie Sbidian

Open source

DOI
10.1007/s40259-026-00815-8
Published
2026-10-30
Container
BioDrugs
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40259-026-00815-8,
  title = {Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users},
  author = {Laetitia Penso and Mounya Abboud and Mahmoud Zureik and Emilie Sbidian},
  year = {2026},
  journal = {BioDrugs},
  doi = {10.1007/s40259-026-00815-8},
  url = {https://doi.org/10.1007/s40259-026-00815-8}
}

RIS

TY  - JOUR
TI  - Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users
AU  - Laetitia Penso
AU  - Mounya Abboud
AU  - Mahmoud Zureik
AU  - Emilie Sbidian
PY  - 2026
JO  - BioDrugs
DO  - 10.1007/s40259-026-00815-8
UR  - https://doi.org/10.1007/s40259-026-00815-8
ER  - 

APA

Penso, L., Abboud, M., Zureik, M., & Sbidian, E. (2026). Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users. BioDrugs. https://doi.org/10.1007/s40259-026-00815-8

Source records